8-hydroxy-2-(di-n-propylamino)tetralin has been researched along with 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Empson, RM; Gloveli, T; Heinemann, U; Schmitz, D | 1 |
1 other study(ies) available for 8-hydroxy-2-(di-n-propylamino)tetralin and 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline
Article | Year |
---|---|
Serotonin reduces polysynaptic inhibition via 5-HT1A receptors in the superficial entorhinal cortex.
Topics: 2-Amino-5-phosphonovalerate; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Entorhinal Cortex; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Free Radical Scavengers; Membrane Potentials; Neural Inhibition; Organ Culture Techniques; Piperazines; Quinoxalines; Rats; Rats, Wistar; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Ritanserin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Synapses | 1998 |